Sir,
This is in response to the article' Do Indian researchers read Indian research? a reappraisal, four years later', published in April 2000 (No.2, f Vol.42) issue of your journal. The authors of this article have documented their observations on my article 'Transsexualism in Schizophrenia : a case report ' (April, 1998, Vol.40, No. 2) that I did not refer to their article, 'Behaviour Therapy for Trans-sexualism' (July,1995, Vol.37, No. 3) in my paper. The authors cited this case as an example of the fact that Indian (Psychiatric) Researchers do not read Indian (Psychiatric) Research Published in Indian Journal of Psychiatry.
Without going through the contents of my article, the authors seem to have concluded that an article on transsexualism must be referenced in all subsequent publications on transsexualism irrespective of its relevance. This article in question deals with the treatment of transsexualism with behaviour therapy while my paper is a case report on transsexualism with schizophrenia with the focus of the article being entirely on manifestation of transsexualism in the setting of schizophrenia or psychosis. Not only I did not refer to the authors' above mentioned "Indian" article, I also did not refer to several other "not-Indian" articles on transsexualism. The focus of both the articles is different and I did not find it appropriate to mention that article in my paper through I am well aware of its publication. Authors should have done some home work before reaching their conclusion This reflects how much authors themselves read Indian research. Indian Journal of Psychiatry is a valued possession for its readers and no one can take liberty to play with their sentiments by their irresponsible writings. 
AGRANULOCYTOSIS DURING CLOZAPINE THERAPY Sir,
Agranulocytosis, defined as granulocyte count less than 500-cells/mm\ is a serious complication of clozapine therapy It occurs frequently in the first three months and 95% cases occur within the first six months of treatment (Young et al.,1998) . Its one-year cumulative incidence is 0.8% (Alvir et al.,1993) . This complication has no relation with clozapine dose and presently, it is difficult to predict who will develop it (Honigfeld et al., 1998) In contrast to the Western literature, only one case of clozapine-induced agranulocytosis has been reported in the Indian counterpart (Srinivasan & Thomas,1998 ) at 18th week. Concurrently he developed pyrexia (39°C) and all the drugs were immediately discontinued. Following an urgent physician consultation, along with reverse isolation, broad-spectrum antibiotics were started. Since there were practical difficulties in acquiring granulocyte-colonystimulating factor (G-CSF), lithium 300 mg/day, in view of its WBC count increasing property, was started. He gradually improved and the total WBC count, on the fourth day of conservative management, was4,500-cells/mm 3 (neutrophils ) count of 630-cells/mm 3 ). This patient was on clozapine and sodium valproate at the onset of WBC decline. An association between sodium valproate and neutropenia was reported earlier (Symon & Russel,1983) ; however, its association with agranulocytosis is unknown. Presently, sodium valproate is considered as the agent of first choice in the management of clozapine-induced seizures (Young et al.,1998) . Due to these reasons, we considered clozapine but not sodium valproate as the causative agent for agranulocytosis.
Our patient had no known risk factors of agranulocytosis such as female sex, increased age and age less than 21 years (Alviretal., 1993; Alvir & Liberman, 1994) . A notable finding in this patient was persisting eosinophilia that peaked just before the onset of WBC decline. This is an interesting phenomenon given the fact that an association has been noted between clozapine-i induced eosinophilia and neutropenia (Galletly et al.,1996; Lucht & Rietchel, 1998) . Since eosinophilia has higher incidence rate (Hummer et al., 1994) and all patients with eosinophilia do not develop either neutropenia or agranulocytosis, we could not explain the significance of eosinophilia. There are possibilities of influence of some intervening factors, hence, we suggest that other factors that might precipitate agranulocytosis, in the presence of eosinophilia, should be investigated.
